Macromolecular Bioscience · 2018 · 66 citations · 24 references
PharmacyBiomedical EngineeringBiotechnologyDrug DeliveryGene DeliveryVaccinologyMrna Vaccine TechnologyNucleic Acid VaccinesVaccine DeliveryVaccine Delivery SystemsVaccine PlatformsVaccine StabilityBiodegradable Vaccine CarriersImplantable Vaccine Delivery SystemsInjectable Delivery SystemsMessenger Ribonucleic Acid (Mrna) Vaccine FormulationsMessenger Rna (Mrna) VaccinesMrna DeliveryMrna Delivery SystemsMrna Transfection Efficiency
mRNA vaccines are highly specific and effective, yet their rapid degradation and low in‑vivo transfection limit use, prompting development of nonviral, injectable delivery systems. This study introduces an injectable chitosan‑alginate gel scaffold for local mRNA vaccine delivery. The scaffold’s biodegradation and biocompatibility were quantified, and its ability to drive in‑vivo mRNA transgene expression and antigen‑specific cellular and humoral responses was evaluated. Scaffold‑mediated delivery produced five‑fold higher luciferase expression than systemic injection, enhanced T‑cell proliferation and IFN‑γ secretion, and induced IgG responses by week 1, indicating a viable alternative to conventional nucleic‑acid immunization.
mRNA vaccines have proven to be more stable, effective, and specific than protein/peptide-based vaccines in stimulating both humoral and cellular immune response. However, mRNA's fast degradation rate and low-transfection efficiency in vivo impede its potential in vaccination. Recent research in gene delivery has focused on nonviral vaccine carriers and either implantable or injectable delivery systems to improve transgene expression in vivo. Here, an injectable chitosan-alginate gel scaffold for the local delivery of mRNA vaccines is reported. Gel scaffold biodegradation rates and biocompatibility are quantified. Scaffold-mediated mRNA in vivo transgene expression as well as ovalbumin antigen specific cellular and humoral immune responses are evaluated in vivo. Luciferase reporter protein expression resulting from mRNA lipoplex-loaded gel scaffolds is five times higher than systemic injection. Compared to systemic injections of naked mRNA or mRNA:lipoplexes, elevated levels of T cell proliferation and IFN-γ secretion are seen with in vivo scaffold-mediated mRNA lipoplex delivery. Furthermore, a humoral response (ovalbumin antigen specific IgG levels) is observed as early as week 1 for scaffold-mediated mRNA lipoplex delivery, while protein-based immunization did not elicit IgG production until 2 weeks post-injection. Results suggest that injectable scaffold mRNA vaccine delivery maybe a viable alternative to traditional nucleic acid immunization methods.
24
Infection-mimicking materials to program dendritic cells in situ
Omar A. Ali, Nathaniel Huebsch, Lan Cao et al. · Nature Materials · 2009 · 429 citations · Full text